# Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial

> **NCT06614036** · PHASE4 · RECRUITING · sponsor: **Koen Munters** · enrollment: 148 (estimated)

## Conditions studied

- Sedation for Diagnostic Gastroscopy

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06614036
- **Lead sponsor:** Koen Munters
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-21
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614036, "Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06614036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*